Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

iBio

0.8500
+0.00450.53%
Post-market: 0.85000.00000.00%19:29 EDT
Volume:738.39K
Turnover:645.01K
Market Cap:17.22M
PE:-0.49
High:0.9100
Open:0.8580
Low:0.8412
Close:0.8455
52wk High:6.89
52wk Low:0.5562
Shares:20.25M
Float Shares:18.61M
Volume Ratio:2.09
T/O Rate:3.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7504
EPS(LYR):-1.7504
ROE:-101.52%
ROA:-44.79%
PB:1.16
PE(LYR):-0.49

Loading ...

OverviewCompanyNewsFilings

Trump Says Pharma Tariffs Coming Very Soon

Reuters
·
Jun 17

BRIEF-IBio Initiates Non-Human Primate Study Of First-In-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention In Weight Regain After GLP-1 Treatment

Reuters
·
Jun 16

IBio Files Prospectus for Resale of About 11.3 Million Shares

MT Newswires Live
·
Jun 13

Vaccine Stocks Surge with Moderna up 11%

Tiger Newspress
·
May 20

Trump Says He Will Cut Drug Prices by 59%

Reuters
·
May 12

iBio Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 05

BRIEF-iBio Reports Fiscal Third Quarter 2025 Financial Results

Reuters
·
May 02

iBio Q3 EPS $(0.49) Misses $(0.34) Estimate

Benzinga
·
May 02

Press Release: iBio Reports Fiscal Third Quarter 2025 Financial Results

Dow Jones
·
May 02

BRIEF-Ibio Inc Enters Exclusive License Agreement With AstralBio

Reuters
·
Apr 23

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Sep 05, 2025 Pre-Market
Financial Report Announcement
May 02, 2025 Pre-Market
Financial Report Announcement
Feb 10, 2025 Post Market
Financial Report Announcement
Nov 12, 2024 Post Market
Financial Report Announcement
Sep 20, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.49
Current
-3.73
Sector Average
49.48%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.49
Maximum
-0.04
+1 STD
1.74
Minimum
-26.80
-1 STD
-9.21
Average
-3.73

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.